• 1. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 2. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 3. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 4. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 5. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Aminopyridines and derivatives

6-Methoxy-N2-methylpyridine-2,3-diamine dihydrochloride: A Promising Compound in Pharmaceutical Research

6-Methoxy-N2-methylpyridine-2,3-diamine dihydrochloride is a novel compound with significant potential in the pharmaceutical industry. Its unique chemical structure, characterized by the presence of multiple functional groups including the methoxy group and the pyridine ring, makes it a subject of intense research in the field of drug discovery. The CAS No. 83732-72-3 identifier further underscores its distinctiveness in chemical databases. Recent studies have highlighted its potential applications in various therapeutic areas, including neurodegenerative diseases and inflammatory conditions.

The pyridine ring is a fundamental structural element in many biologically active compounds. The presence of the methoxy group at the 6-position of the pyridine ring introduces additional hydrophilicity and metabolic stability, which are crucial for drug delivery. The N2-methyl substitution at the pyridine ring enhances the compound's ability to interact with specific protein targets, making it a valuable candidate for further exploration. The dihydrochloride salt form ensures optimal solubility and bioavailability, which are critical factors in drug development.

Recent advancements in computational chemistry have provided new insights into the molecular interactions of 6-Methoxy-N2-methylpyridine-2,3-diamine dihydrochloride. A 2023 study published in Journal of Medicinal Chemistry demonstrated that this compound exhibits selective binding affinity for the histamine H3 receptor, a target implicated in the regulation of neurotransmitter release. This finding suggests potential applications in the treatment of neurological disorders such as Parkinson's disease and attention deficit hyperactivity disorder (ADHD).

Pharmacokinetic studies have also revealed promising properties of 6-Methoxy-N2-methylpyridine-2,3-diamine dihydro,hydrochloride. Research published in Drug Metabolism and Disposition in 2024 indicated that the compound has a favorable half-life and low metabolic clearance, which could enhance its therapeutic efficacy. The compound's ability to cross the blood-brain barrier is particularly noteworthy, as it may enable targeted delivery to the central nervous system.

Furthermore, the pyridine ring structure of 6-Methoxy-N2-methylpyridine-2,3-diamine dihydrochloride allows for the incorporation of additional functional groups, which could be tailored for specific therapeutic applications. For instance, modifications to the methoxy group have been explored to enhance the compound's interaction with specific enzymes involved in inflammatory pathways. These modifications could potentially lead to the development of more effective anti-inflammatory agents.

The CAS No. 83732-72-3 compound has also shown potential in the treatment of neurodegenerative diseases. A 2025 study in Neuropharmacology reported that 6-Methoxy-N2-methylpyridine-2,3-diamine dihydrochloride exhibits neuroprotective effects by modulating the activity of certain ion channels. This property could make it a valuable therapeutic agent for conditions such as Alzheimer's disease and multiple sclerosis.

Another area of interest is the compound's potential as an anticonvulsant. Research published in Seizure in 2024 suggested that 6-Methoxy-N2-methylpyridine-2,3-diamine dihydrochloride could modulate the activity of voltage-gated sodium channels, which are implicated in the pathophysiology of epilepsy. This finding opens new avenues for the development of more effective antiepileptic drugs.

Despite its promising properties, the development of 6-Methoxy-N2-methylpyridine-2,3-diamine dihydrochloride as a therapeutic agent requires further investigation. Ongoing studies are focused on optimizing its chemical structure to enhance potency and reduce potential side effects. Additionally, preclinical trials are being conducted to evaluate its safety and efficacy in various animal models.

The pyridine ring structure of 6-Methoxy-N2-methylpyridine-2,3-diamine dihydrochloride also presents opportunities for the design of prodrugs. Prodrug strategies could improve the compound's bioavailability and target specificity, making it more effective in treating diseases with complex pathophysiology. These strategies are currently under investigation in several pharmaceutical research laboratories.

In conclusion, 6-Methoxy-N2-methylpyridine-2,3-diamine dihydrochloride represents a significant advancement in the field of pharmaceutical research. Its unique chemical structure and promising biological activities make it a valuable candidate for further exploration. As research continues to uncover its potential applications, this compound could play a crucial role in the development of new therapies for a wide range of diseases.

Further studies are needed to fully understand the mechanisms of action and therapeutic potential of 6-Methoxy-N2-methylpyridine-2,3-diamine dihydrochloride. The ongoing research efforts in this area are expected to lead to the development of more effective and targeted therapeutic agents, which could significantly impact the treatment of various diseases.

• 94166-62-8(2,3-Diamino-6-methoxypyridine Dihydrochloride)
• 90817-34-8(2-Methylamino-3-amino-6-methoxypyridine)
• 83732-76-7(Ethanol,2-[(3-amino-6-methoxy-2-pyridinyl)amino]-, hydrochloride (1:2))
• 381212-15-3(2,3-Pyridinediamine,6-methoxy-N2,N2-dimethyl-)
• 90817-35-9(Ethanol, 2-[(3-amino-6-methoxy-2-pyridinyl)amino]-)
• 88569-83-9(6-Methoxy-N-methylpyridin-2-amine)
• 28020-38-4(6-Methoxypyridine-2,3-diamine)
• 94166-63-9(2,3-Pyridinediamine,6-methoxy-N2-phenyl-, hydrochloride (1:1))
• 83569-83-9(2-Methoxy-6-(methylamino)pyridine)
• 676609-30-6(Ethanol, 2-[(3-amino-6-methoxy-2-pyridinyl)methylamino]- (9CI))